Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech company developing novel peptide therapeutic modalities. He previously was CSO at CovX, a leading peptide-antibody conjugates company; a SVP of Pfizer worldwide R&D and member of the Pfizer Leadership Team; and SVP Research at Ferring Pharmaceuticals, a leading peptide therapeutics company. He is also a co-founder of Cara Therapeutics and the Peptide Therapeutics Foundation and the Annual Peptide Therapeutics Symposium. Dr. Riviere received a Ph.D. in animal physiology and biology from the Institut National Polytechnique, Toulouse, and completed postdoctoral studies at the University of Arizona, Tucson.
